Although fibromyalgia pain can prove difficult to manage, recent study results suggest that individually tailored acupuncture can reduce the intensity of pain experienced by patients with this condition.
Pain Management
Latest News
Advertisement
Advertisement
As computational techniques become more sophisticated, the idea of targeted therapeutic treatments sans adverse effects could become reality.
Although their pharmacokinetics are all similar, here's how they differ.
Which OTC products should these pharmacists recommend?
Substance P can lessen pain response in the peripheral nervous system.
Top news of the day from across the healthcare landscape.
Individuals with moderate or severe pain more likely to develop a prescription opioid use disorder.
Multiple types of spinal cord stimulation could be used to treat chronic back and limb pain.
Low cost medications that are frequently prescribed could potentially be driving up Medicaid drug spending.
Compounds found in rosemary and sage could inhibit pain and inflammatory pathways.
Behavioral therapy and social support could decrease pain levels experienced by patients.
Acute pain is the body's normal response to noxious stimuli.
Top news of the day from across the healthcare landscape.
Although total knee replacement is frequently performed to treat knee arthritis, the procedure is often associated with a number of adverse events.
A recent study indicates that impressions of breakthrough pain differ between patients and providers.
Current guidelines recommend delaying referrals for physical therapy, in part because previous research found that early aggressive therapy contributed to higher health care costs and did not seem to make significant improvements for patients.
After knee surgery, patients were 5 times more likely to use opioids chronically compared with nonsurgical patients.
Patients benefit when pharmacists thoroughly assess pain.
Opioid risks could potentially be sensationalized by the media and lead to less treatment options for patients.
Seventeen states with medical marijuana laws saved Medicare Part D approximately $165.2 million in 2013.
Top news of the day from across the health care landscape.
Pharmacists in all health care settings commonly see what seems like lifelong refills for cyclobenzaprine for musculoskeletal conditions.
The FDA has rejected KemPharm Inc's benzhydrocodone and acetaminophen (Adapaz), a potential abuse-deterrent treatment for acute pain.
Top news of the day from across the healthcare landscape.
The FDA has approved Espero Pharmaceuticals Inc's nitroglycerin sublingual powder (GoNitro) for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease.
Advertisement
Advertisement